-Search query
-Search result
Showing 1 - 50 of 486 items for (author: lee & ws)

EMDB-48575:
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48591:
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9msd:
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9msy:
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-46047:
HIV Env JRFL NFL TD CC3+ trimer in complex with NHP #1 polyclonal Fab (gp120 interface, gp41-FP, gp41-base epitopes)
Method: single particle / : Sewall LM, Ozorowski G, Ward AB

EMDB-46048:
HIV Env ZM233 NFL TD CC3+ trimer in complex with NHP #1,2,3,4 polyclonal Fab (gp41-FP, gp41-base epitopes)
Method: single particle / : Sewall LM, Ozorowski G, Ward AB

EMDB-48283:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490:
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491:
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492:
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493:
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494:
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495:
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

PDB-9mi0:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mia:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mib:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mih:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mii:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-45928:
LJF-085 Fab in complex with HIV Env JRFL NFL TD CC3+ trimer and 35O22 Fab
Method: single particle / : Ozorowski G, Ward AB

EMDB-45929:
LJF-034 Fab in complex with HIV Env JRFL NFL TD CC3+ trimer and 35O22 Fab
Method: single particle / : Ozorowski G, Ward AB

EMDB-45957:
LJF-085 Fab in complex with HIV Env ZM233 NFL TD CC3+ trimer
Method: single particle / : Ozorowski G, Ward AB

EMDB-45978:
LJF-085 Fab in complex with HIV Env ZM233 NFL TD CC3+ dimer and 35O22 Fab
Method: single particle / : Ozorowski G, Ward AB

PDB-9cu5:
LJF-085 Fab in complex with HIV Env JRFL NFL TD CC3+ trimer and 35O22 Fab
Method: single particle / : Ozorowski G, Ward AB

PDB-9cu6:
LJF-034 Fab in complex with HIV Env JRFL NFL TD CC3+ trimer and 35O22 Fab
Method: single particle / : Ozorowski G, Ward AB

PDB-9cv7:
LJF-085 Fab in complex with HIV Env ZM233 NFL TD CC3+ trimer
Method: single particle / : Ozorowski G, Ward AB

EMDB-46004:
Outward-facing OATP1B1 bound to sybody Sb5
Method: single particle / : Sung MW, Lees JA, Han S

EMDB-46005:
Outward-facing Atorvastatin-bound OATP1B1 with sybody Sb5
Method: single particle / : Sung MW, Lees JA, Han S

EMDB-46006:
Outward-facing cyclosporine A-bound OATP1B1 with sybody 5 (Sb5)
Method: single particle / : Sung MW, Lees JA, Han S

PDB-9cy1:
Outward-facing OATP1B1 bound to sybody Sb5
Method: single particle / : Sung MW, Lees JA, Han S

PDB-9cy3:
Outward-facing Atorvastatin-bound OATP1B1 with sybody Sb5
Method: single particle / : Sung MW, Lees JA, Han S

PDB-9cy4:
Outward-facing cyclosporine A-bound OATP1B1 with sybody 5 (Sb5)
Method: single particle / : Sung MW, Lees JA, Han S

EMDB-51951:
Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a yeast expression system.
Method: single particle / : Bahar MW, Sherry L, Stonehouse NJ, Rowlands DJ, Fry EE, Stuart DI

EMDB-51952:
Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC5a) from a yeast expression system.
Method: single particle / : Bahar MW, Sherry L, Stonehouse NJ, Rowlands DJ, Fry EE, Stuart DI

PDB-9h93:
Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a yeast expression system.
Method: single particle / : Bahar MW, Sherry L, Stonehouse NJ, Rowlands DJ, Fry EE, Stuart DI

PDB-9h94:
Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC5a) from a yeast expression system.
Method: single particle / : Bahar MW, Sherry L, Stonehouse NJ, Rowlands DJ, Fry EE, Stuart DI

EMDB-44511:
Structure of human GlcNAc-1-phosphotransferase complexed with the donor substrate UDP-GlcNAc
Method: single particle / : Li H

EMDB-44512:
Structure of a hyperactive S1S3 truncation of the human GlcNAc-1-phosphotransferase
Method: single particle / : Li H

EMDB-41532:
Polyclonal immune complex of Fab binding H2 HA from serum of subject 2-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41533:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-1 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41534:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41535:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41536:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41537:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41538:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-2 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41539:
Polyclonal immune complex of Fab binding H2 HA from serum of subject 3-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB

EMDB-41540:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
Pages: